Monitoring cognitive and psychological alterations in COVID-19 patients: A longitudinal neuropsychological study 2022 Diana et al

Discussion in 'Long Covid research' started by Andy, Dec 7, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    22,406
    Location:
    Hampshire, UK
    Highlights
    • Longitudinal assessment of COVID-19-related cognitive symptoms was performed.
    • Cognitive alterations may extend beyond 1 year after the acute phase.
    • Several borderline scores in memory and executive tests were detected.
    • Longitudinal improvements were observed in several cognitive tests.
    Abstract

    Background

    SARS-COV-2 infection has been associated to long-lasting neuropsychiatric sequelae, including cognitive deficits, that persist after one year. However, longitudinal monitoring has been scarcely performed. Here, in a sample of COVID-19 patients, we monitor cognitive, psychological and quality of life-related profiles up to 22 months from resolution of respiratory disease.

    Methods

    Out of 657 COVID-19 patients screened at Manzoni Hospital (Lecco, Italy), 22 underwent neuropsychological testing because of subjective cognitive disturbances at 6 months, 16 months, and 22 months. Tests of memory, attention, and executive functions were administered, along with questionnaires for depressive and Post-traumatic stress disorder (PTSD) symptoms, psychological well-being and quality of life. Cross-sectional descriptives, correlational, as well as longitudinal analyses considering COVID19-severity were carried out. A preliminary comparison with a sample of obstructive sleep apneas patients was also performed.

    Results

    Around 50% of COVID-19 patients presented with cognitive deficits at t0. The most affected domain was verbal memory. Pathological scores diminished over time, but a high rate of borderline scores was still observable. Longitudinal analyses highlighted improvements in verbal and non-verbal long term memory, as well as attention, and executive functioning. Depression and PTSD-related symptoms were present in 30% of patients. The latter decreased over time and were associated to attentional-executive performance.

    Conclusions

    Cognitive dysfunctions in COVID-19 patients may extend over 1 year, yet showing a significant recovery in several cases. Cognitive alterations are accompanied by a significant psychological distress. Many patients displaying borderline scores, especially those at higher risk of dementia, deserve clinical monitoring.

    Open access, https://www.jns-journal.com/article/S0022-510X(22)00373-2/fulltext
     
    Sean, Peter Trewhitt, RedFox and 3 others like this.

Share This Page